AAPS Co-Sponsors Workshop Focusing On Modified Release Drug Products
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Conferences; Pharmacy / Pharmacist; Regulatory Affairs / Drug Approvals
Article Date: 23 Sep 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Therapeutic equivalence to be highlighted in event co-sponsored by the Product Quality Research Institute and the International Pharmaceutical Federation
WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. This workshop is co-sponsored with the Product Quality Research Institute (PQRI) and International Pharmaceutical Federation (FIP).
WHAT: In partnership with PQRI and FIP, AAPS is pleased to present the workshop Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products. This two-day event will discuss some of the challenges presented by the complexity of Modified Release (MR) dosage forms. The workshop will consist of talks by experts from the pharmaceutical industry, academia, and the U.S. Food and Drug Administration.
WHY:This workshop aims to convene pharmaceutical scientists from academia, industry and regulatory agencies to review advances and regulations related to MR dosage forms, examine current and emerging issues, and identify critical paths to establishing scientific and regulatory standards for ensuring therapeutic equivalence and therapeutic interchangeability of MR products.
WHEN: October 1-2, 2009
Sheraton Inner Harbor Hotel
Baltimore, MD, USA
Source:
Joseph Catapano
American Association of Pharmaceutical Scientists
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/164854.php>
APA
http://www.medicalnewstoday.com/releases/164854.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



